Haemonetics Corp (FRA:HAZ)
€ 79 1 (1.28%) Market Cap: 3.99 Bil Enterprise Value: 4.87 Bil PE Ratio: 33.69 PB Ratio: 4.65 GF Score: 28/100

Q2 2023 Haemonetics Corp Earnings Call Transcript

Nov 07, 2022 / 01:00PM GMT
Release Date Price: €82.5 (+3.13%)
Operator

Good day, and welcome to the Haemonetics Corporation Second Quarter Fiscal 2023 Earnings Call. (Operator Instructions) As a reminder, this call may be recorded. I would now like to turn the call over to Olga Guyette, Senior Director, Investor Relations and Treasury. You may begin.

Olga Guyette
Haemonetics Corporation - Director of IR

Good morning, everyone. Thank you for joining us for Haemonetics' Second Quarter Fiscal '23 Conference Call and Webcast. I'm joined today by Chris Simon, our CEO; George Strong, President of our Global Hospital business; and James D'Arecca, our CFO. This morning, we posted our second quarter and first half fiscal '23 results through our Investor Relations website, along with updates our fiscal '23 guidance and the analytical tables with the information that we'll refer to on this call.

Unless otherwise noted, all revenue growth rates we'll discuss today are organic and exclude the impact of currency fluctuations, strategic axes of product lines, acquisitions and divestitures. Additionally, to help investors understand

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot